Google Research just released a fascinating new paradigm called “Nested Learning” to solve one of the most persistent headaches in AI: “catastrophic forgetting.” In traditional machine learning, models are often static. When you teach them a new task, they tend…
When cars and airplanes arrived, did we spend less time traveling? The opposite happened. Initially, yes, cars made existing trips faster. But then we realized what else became possible. Weekend getaways. Cross-country moves. Global business. We didn’t reduce travel. We…
I recently researched the future of AI in pharmacovigilance, analyzing relevant literature and discussing with three top AI models (GPT-5.1, Claude Opus-4.5, and Gemini-3.0). Here is the realistic roadmap and the critical focus areas that emerged from my research stripped…
A recent MIT report highlighted a startling statistic. 95% of investments in Generative AI have produced zero returns. This number is alarming, but for those of us in drug discovery and pharmacovigilance, it shouldn’t be surprising. The problem isn’t the…
We are drowning in data but starving for insight. Every day, the biomedical literature grows by thousands of new publications. Clinical trial databases expand. Real-world evidence accumulates. Adverse event reports pile up. And somewhere buried in all of that noise…
Today feels like a small milestone. I have posted on LinkedIn every single day for a month. It might be too early to celebrate, but it is worth acknowledging. According to some studies, more than half of the people who…
I just finished watching a fascinating interview with Ilya Sutskever, and it raises a critical question for all of us in R&D and Pharmacovigilance. For years, the promise of massive AI models felt tied only to scaling: more compute, more…
Many people worry that in the age of AI, important human capabilities like critical thinking will decline. Some studies even suggest that when people rely on tools like ChatGPT, they think less deeply. I believe there is no need to…
The White House just released the Genesis Mission, outlining a coordinated national effort to advance science, technology, and AI. It aims to identify major challenges across key domains and mobilize federal, academic, and private-sector capabilities to address them. A core…
I recently read about the FDA’s investigation into a reported pediatric death in a patient treated with Adzynma. Situations like this are always difficult. At the same time, they remind us why post-marketing safety work is so important for the…
